{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:04:01Z","timestamp":1791993841533,"version":"4.4.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2008,11,28]],"date-time":"2008-11-28T00:00:00Z","timestamp":1227830400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1000225","type":"journal-article","created":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T17:46:59Z","timestamp":1227808019000},"page":"e1000225","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":176,"title":["Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates"],"prefix":"10.1371","volume":"4","author":[{"given":"Thomas W.","family":"Geisbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Daddario-DiCaprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Grolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Paragas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennox","family":"Matthias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Jahrling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,11,28]]},"reference":[{"key":"ref1","first-page":"1409","article-title":"Filoviridae: Marburg and Ebola Viruses.","author":"A Sanchez","year":"2006"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(07)61880-7","article-title":"Ebola outbreak in Uganda \u201catypical\u201d, say experts.","volume":"370","author":"Z Alsop","year":"2008","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management.","volume":"287","author":"L Borio","year":"2002","journal-title":"JAMA"},{"key":"ref4","article-title":"Bioterrorism Agents\/Diseases."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges.","volume":"10","author":"TW Geisbert","year":"2004","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/JVI.00105-07","article-title":"Successful topical respiratory tract immunization of primates against Ebola virus.","volume":"81","author":"A Bukreyev","year":"2007","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine platform protects non-human primates against lethal challenge with either Ebola virus or Marburg virus.","volume":"11","author":"SM Jones","year":"2005","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1371\/journal.pmed.0030177","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.","volume":"3","author":"NJ Sullivan","year":"2006","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.","volume":"424","author":"NJ Sullivan","year":"2003","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates.","volume":"408","author":"NJ Sullivan","year":"2000","journal-title":"Nature"},{"key":"ref11","article-title":"Complete protection of nonhuman primates against multi-strain Ebola and Marburg virus infections.","author":"DL Swenson","year":"2008"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.","volume":"196","author":"KL Warfield","year":"2007","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","article-title":"Effective post-exposure treatment of Ebola infection.","volume":"3","author":"H Feldmann","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/JVI.00456-08","article-title":"Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates.","volume":"82","author":"TW Geisbert","year":"2008","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/oxfordjournals.aje.a121094","article-title":"Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome.","volume":"90","author":"CD Brandt","year":"1969","journal-title":"Am J Epidemiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1542\/peds.101.6.1013","article-title":"Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors.","volume":"101","author":"PA Piedra","year":"1998","journal-title":"Pediatrics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI119149","article-title":"Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity.","volume":"99","author":"AH Schulick","year":"1997","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1126\/science.318.5853.1048","article-title":"AIDS research. Did Merck's failed HIV vaccine cause harm?","volume":"318","author":"J Cohen","year":"2007","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20072681","article-title":"The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?","volume":"205","author":"RP Sekaly","year":"2008","journal-title":"J Exp Med"},{"key":"ref20","first-page":"1121","article-title":"Rhabdoviridae: The viruses and their replication.","author":"RR Wagner","year":"1996"},{"key":"ref21","article-title":"2006 report on the Global AIDS epidemic.","year":"2008"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virol.2007.04.012","article-title":"HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.","volume":"366","author":"AD Cristillo","year":"2007","journal-title":"Virology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/QAD.0b013e3282f35551","article-title":"CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques.","volume":"22","author":"V Vieillard","year":"2008","journal-title":"AIDS"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.","volume":"78","author":"M Garbutt","year":"2004","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/514310","article-title":"Evaluation of immune globulin and recombinant interferon \u03b1-2b for treatment of experimental Ebola virus infections.","volume":"179","author":"PB Jahrling","year":"1999","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.","volume":"163","author":"TW Geisbert","year":"2003","journal-title":"Am J Pathol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/aid.1998.14.183","article-title":"Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction.","volume":"14","author":"KT Suryanarayana","year":"1998","journal-title":"AIDS Res Hum Retrovir"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"S323","DOI":"10.1086\/520589","article-title":"Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus.","volume":"196","author":"T Larsen","year":"2007","journal-title":"J Infect Dis"},{"key":"ref29","first-page":"140","article-title":"Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure.","volume":"120","author":"NK Jaax","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1128\/JVI.00959-06","article-title":"Cross-protection against Marburg virus strains using a live, attenuated recombinant vaccine.","volume":"80","author":"KM Daddario-DiCaprio","year":"2006","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever.","volume":"2(6)","author":"TW Geisbert","year":"2005","journal-title":"PLoS Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1086\/520591","article-title":"Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever.","volume":"196","author":"SM Jones","year":"2007","journal-title":"J Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.","volume":"367","author":"KM Daddario-DiCaprio","year":"2006","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/aid.2004.20.989","article-title":"Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes.","volume":"20","author":"MA Egan","year":"2004","journal-title":"AID Res Human Retroviruses"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"11079","DOI":"10.1128\/JVI.75.22.11079-11087.2001","article-title":"Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.","volume":"75","author":"JS Kahn","year":"2001","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2005.06.016","article-title":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine.","volume":"340","author":"SU Kapadia","year":"2005","journal-title":"Virology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1128\/JVI.80.9.4447-4457.2006","article-title":"Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge.","volume":"80","author":"RJ Natuk","year":"2006","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1128\/JVI.72.6.4704-4711.1998","article-title":"Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge.","volume":"72","author":"A Roberts","year":"1998","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.","volume":"106","author":"NF Rose","year":"2001","journal-title":"Cell"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/JVI.74.10.4652-4657.2000","article-title":"Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.","volume":"74","author":"B Schlereth","year":"2000","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1128\/JVI.77.14.8039-8047.2003","article-title":"Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host.","volume":"77","author":"I Martinez","year":"2003","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors.","volume":"73","author":"A Roberts","year":"1999","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virol.2006.10.026","article-title":"Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates.","volume":"360","author":"JE Johnson","year":"2007","journal-title":"Virology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/JVI.01515-07","article-title":"Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice.","volume":"82","author":"D Cooper","year":"2008","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/JVI.10.6.1231-1235.1972","article-title":"The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody.","volume":"10","author":"JM Kelley","year":"1972","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1128\/JVI.77.9.5524-5528.2003","article-title":"The cell-rounding activity of the vesicular stomatitis virus matrix protein is due to the induction of cell death.","volume":"77","author":"SA Kopecky","year":"2003","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1128\/JVI.75.24.12169-12181.2001","article-title":"Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus.","volume":"75","author":"SA Kopecky","year":"2001","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.ppat.0030009","article-title":"Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys.","volume":"3","author":"WB Oswald","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1086\/520587","article-title":"Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.","volume":"196","author":"PB Jahrling","year":"2007","journal-title":"J Infect Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.4049\/jimmunol.173.9.5372","article-title":"Vaccination in humans generates broad T cell cytokine responses.","volume":"173(9)","author":"SC De Rosa","year":"2004","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1089\/vim.2004.17.390","article-title":"Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques.","volume":"17","author":"DS Reed","year":"2004","journal-title":"Viral Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1096\/fj.06-6151com","article-title":"Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses.","volume":"20","author":"K Yaddanapudi","year":"2006","journal-title":"FASEB J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3201\/eid0805.010284","article-title":"Evaluation in nonhuman primates of vaccines against Ebola virus.","volume":"8","author":"TW Geisbert","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1128\/JVI.76.18.9176-9185.2002","article-title":"Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.","volume":"76","author":"M Rao","year":"2002","journal-title":"J Virol"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1000225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T14:51:33Z","timestamp":1589208693000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1000225"}},"subtitle":[],"editor":[{"given":"Yoshihiro","family":"Kawaoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,11,28]]},"references-count":54,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2008,11,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1000225","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,28]]}}}